Medlive Technology Co (HKSE:02192) Change In Receivables : HK$-17.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Change In Receivables?

Medlive Technology Co's change in receivables for the quarter that ended in Dec. 2023 was HK$-12.1 Mil. It means Medlive Technology Co's Accounts Receivable increased by HK$12.1 Mil from Jun. 2023 to Dec. 2023 .

Medlive Technology Co's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-17.8 Mil. It means Medlive Technology Co's Accounts Receivable increased by HK$17.8 Mil from Dec. 2022 to Dec. 2023 .

Medlive Technology Co's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$120.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Medlive Technology Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 84.07.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Medlive Technology Co's liquidation value for the six months ended in Dec. 2023 was HK$4,631.9 Mil.

Medlive Technology Co Change In Receivables Historical Data

The historical data trend for Medlive Technology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Change In Receivables Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-25.03

1.42

-38.83

-27.97

-17.85

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial					-22.93	-4.12	-24.05	-5.75	-12.10

Medlive Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-17.8 Mil.

Medlive Technology Co (HKSE:02192) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Medlive Technology Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	120.175	/	260.864	*	91
=	84.07

2. In Ben Graham's calculation of liquidation value, Medlive Technology Co's accounts receivable are only considered to be worth 75% of book value:

Medlive Technology Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4813.606	-	271.929	+	0.75 * 120.175	+	0.5 * 0.108
=	4,631.9

Medlive Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
M3, Inc.	2101 Beneficial owner
Sony Group Corporation	2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng	2101 Beneficial owner
Liu Lingdi	2101 Beneficial owner
Tian Lixin	2101 Beneficial owner
Brown Brothers Harriman & Co.	2502 Approved lending agent
Fidelity Funds	2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co (HKSE:02192) Headlines

No Headlines